Abstract:Background: Traumatic brain injury (TBI) is a major cause of morbidity and mortality, affecting millions annually worldwide. Although the majority of TBI patients return to premorbid baseline, a subset of patient can develop persistent and often debilitating neurocognitive and behavioral changes. The etiology of TBI within the clinical setting is inherently heterogenous, ranging from sport related injuries, fall related injuries and motor vehicle accidents in the civilian setting, to blast injuries in the military setting. Objective: Animal models of TBI, offer the distinct advantage of controlling for injury modality, duration and severity. Furthermore, preclinical models of TBI have provided the necessary temporal opportunity to study the chronic neuropathological sequelae of TBI, including neurodegenerative sequelae such as tauopathy and neuroinflammation within the finite experimental timeline. Despite the high prevalence of TBI, there are currently no disease modifying regimen for TBI, and the current clinical treatments remain largely symptom based. The preclinical models have provided the necessary biological substrate to examine the disease modifying effect of various pharmacological agents and have imperative translational value. Methods: The current review will include a comprehensive survey of well-established preclinical models, including classic preclinical models including weight drop, blast injury, fluid percussion injury, controlled cortical impact injury, as well as more novel injury models including closed-head impact model of engineered rotational acceleration (CHIMERA) models and closed-head projectile concussive impact model (PCI). In addition to rodent preclinical models, the review will include an overview of other species including large animal models and Drosophila . Results: There are major neuropathological perturbations post TBI captured in various preclinical models, which include neuroinflammation, calcium dysregulation, tauopathy, mitochondrial dysfunction and oxidative stress, axonopathy, as well as glymphatic system disruption. Conclusion: The preclinical models of TBI continue to offer valuable translational insight, as well as essential neurobiological basis to examine specific disease modifying therapeutic regimen.

Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets

Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

'Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope

Traumatic Brain Injury: A Comprehensive Review of Biomechanics and Molecular Pathophysiology

The neuroprotective potential of phytochemicals in traumatic brain injury: mechanistic insights and pharmacological implications

Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs

Traumatic brain injury: Symptoms to systems in the 21st century

Colloidal therapeutics in the management of traumatic brain injury: Portray of biomarkers and drug-targets, preclinical and clinical pieces of evidence and future prospects

The Neuroendothelial Axis In Traumatic Brain Injury: Mechanisms Of Multiorgan Dysfunction, Novel Therapies, And Future Directions

The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Pathophysiology-Based Management of Secondary Injuries and Insults in TBI

Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury

[Injury mechanism, clinical status and prospects of traumatic brain injury]

Biomarkers and New Pharmacological Targets

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases

Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?

Mechanisms of Blood–Brain Barrier Dysfunction in Traumatic Brain Injury

From spreading depolarization to blood-brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms